GlobeNewswire Inc.··NaAlamar Biosciences Posts Record Q1 Revenue as IPO Fuels Growth Strategy
Alamar Biosciences reported record Q1 2026 revenue of $26.0M, nearly doubling year-over-year following April IPO that raised $197.8M.
ALMRIPOnet loss
A
$ALMR
1 article found1 positive
0 negative
0 neutral